Related Experiment Video
Updated: Jun 22, 2026
10:04
Tractable In Vivo Reprogramming of Tumor Cells to Type 1 Conventional Dendritic Cell-like Cells
Published on: August 1, 2025
Dendritic cell-based cancer immunotherapies.
Shin-ichiro Fujii1, Takuya Takayama, Miki Asakura
1Research Unit for Cellular Immunotherapy, Research Center for Allergy and Immunology, Institute of Physical and Chemical Research, Yokohama RIKEN, Yokohama, Kanagawa 230-0045, Japan. fujiis@rcai.riken.jp
Archivum Immunologiae Et Therapiae Experimentalis
|May 30, 2009
Summary
Dendritic cell (DC) immunotherapies show limited success. New strategies focus on mimicking natural immune responses for better antitumor immunity by understanding DC interactions with innate immune cells.
Area of Science:
- Immunology
- Cancer immunotherapy
- Cellular immunology
Background:
- Dendritic cells (DCs) are crucial for linking innate and adaptive immunity.
- DCs are a logical target for novel immunotherapies.
- Previous DC-based immunotherapies have had limited clinical efficacy.
Purpose of the Study:
- To improve antitumor immunotherapeutic strategies.
- To tailor strategies by understanding in vivo immune responses.
- To augment DC function from innate cell activation to T cell priming.
Main Methods:
- Analyzing the natural sequence of immune events in vivo.
- Investigating interactions between innate immune cells and DCs.
- Developing strategies to recapitulate effective immune cascades.
Main Results:
- Past ex vivo DC strategies overlooked crucial innate immune interactions.
- Understanding the natural immune cascade is key to effective DC vaccination.
- Current strategies aim to replicate in vivo events for enhanced responses.
Conclusions:
- Effective antitumor immunity requires a comprehensive understanding of DC-mediated immune responses.
- Future immunotherapies should integrate innate immune cell dynamics.
- Tailoring DC vaccination to mimic natural immune processes holds promise for improved efficacy.
Related Concept Videos
01:27Tumor Immunotherapy
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
01:30Cancer Vaccines
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
01:27Cytotoxic T Cells-mediated Immune Response
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
01:40Cell-mediated Immune Responses
Overview
02:49Cancer Therapies
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...